+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 75Years
All Genders
ID07017686

Safety Study of Abdominal Vagus Nerve Stimulation Device for Adults with Moderate to Severe Rheumatoid Arthritis Not Responding to Medication

Led by The Bionics Institute of Australia · Updated on 2026-10-02

5

Participants Needed

3

Research Sites

221 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety of abdominal vagus nerve stimulation aVNS for adults with moderate to severe rheumatoid arthritis RA that has not improved with medication. This open-label study focuses on adult-onset RA patients who have drug-refractory symptoms. The goal is to assess safety, device performance, and any potential benefits of the aVNS device over time. Participants will have the aVNS device implanted through keyhole surgery. Starting two weeks after implantation, stimulation will be delivered daily for about 3 hours per day over a 22-week period. The device is controlled by the participant using a controller to switch it on and off. After this initial phase, participants may continue using the device, which will stay implanted unless removal is clinically needed or requested by the participant. Throughout the study, participants will undergo clinical assessments of RA symptoms and device performance at 2, 6, 12, and 24 weeks post-surgery. Following the initial treatment phase, participants will be monitored twice yearly for up to 5 years to track safety and device effects. Total participation in the trial lasts about 5 years, including follow-up monitoring and evaluations.

CONDITIONS

Brief Title

The Reboot Study: A Safety Study of Abdominal Vagus Nerve Stimulation for Moderate to Severe Drug Refractory Rheumatoid Arthritis

Research Team

A

A/Prof Shereen Oon, MBBS, PhD

A

Angela Chia, RN

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here